Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FETrp PET/CT Imaging in Human Gliomas
NCT07735819Phase 2Not yet recruiting
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Sep 2026
- Primary completion
- Jun 2031
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]fluoroethyltryptophan in glioma, glioblastoma (GBM), sponsored by Barbara Ann Karmanos Cancer Institute. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
[18F]fluoroethyltryptophan
03
Conditions
gliomaglioblastoma (GBM)
Beyond the preview
Go deeper on NCT07735819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07735819.